Balyasny Asset Management’s MedEquities Realty Trust, Inc. MRT Stock Holding History

Balyasny Asset Management’s Portfolio MRT Stock Details MRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-267,822	Closed	-$1.83M	–	1792
2018 Q4	$1.83M	Buy	267,822 +73,776	+38%	+$579K	0.01%	738
2018 Q3	$1.89M	Buy	194,046 +148,190	+323%	+$1.57M	0.01%	997
2018 Q2	$505K	Sell	45,856 -21,550	-32%	-$222K	﹤0.01%	1353
2018 Q1	$708K	Buy	67,406 +13,500	+25%	+$143K	﹤0.01%	1346
2017 Q4	$605K	Buy	53,906 +28,053	+109%	+$318K	﹤0.01%	1494
2017 Q3	$304K	Buy	25,853 +12,369	+92%	+$147K	﹤0.01%	1530
2017 Q2	$170K	Sell	13,484 -22,989	-63%	-$275K	﹤0.01%	1392
2017 Q1	$409K	Sell	36,473 -216,900	-86%	-$2.42M	﹤0.01%	1330
2016 Q4	$2.81M	Sell	253,373 -151,927	-37%	-$1.7M	0.02%	824
2016 Q3	$4.76M	Buy	+405,300	New	+$4.73M	0.03%	513

Other funds holding MRT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Chicago Capital Management Chicago, Illinois $112M AUM 76.54% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Balyasny Asset Management's MRT Position: Q1 2019 in Review

Balyasny Asset Management sold out of MedEquities Realty Trust, Inc. (MRT) in Q1 2019, closing a stake of 267,822 shares — an estimated $1.83M sold.

Balyasny Asset Management first reported a position in MRT in Q3 2016 and held it in 10 quarters. The position peaked at $4.76M in Q3 2016. 103 funds tracked by Wall St. Rank hold MRT as of Q1 2019.

Balyasny Asset Management reported no remaining MedEquities Realty Trust, Inc. position as of Q1 2019 after selling out during the quarter.
Balyasny Asset Management sold 267,822 MedEquities Realty Trust, Inc. shares in Q1 2019, an estimated $1.83M.
Balyasny Asset Management first reported a position in MedEquities Realty Trust, Inc. in Q3 2016 and held it in 10 quarters.
Balyasny Asset Management's MedEquities Realty Trust, Inc. position peaked at $4.76M in Q3 2016.
103 funds tracked by Wall St. Rank held MedEquities Realty Trust, Inc. as of Q1 2019.

Based on Balyasny Asset Management's 13F filing for Q1 2019, filed 15 May 2019.